X-133536201-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_004484.4(GPC3):c.1666G>A(p.Gly556Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004484.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPC3 | NM_004484.4 | c.1666G>A | p.Gly556Arg | missense_variant | Exon 8 of 8 | ENST00000370818.8 | NP_004475.1 | |
GPC3 | NM_001164617.2 | c.1735G>A | p.Gly579Arg | missense_variant | Exon 9 of 9 | NP_001158089.1 | ||
GPC3 | NM_001164618.2 | c.1618G>A | p.Gly540Arg | missense_variant | Exon 8 of 8 | NP_001158090.1 | ||
GPC3 | NM_001164619.2 | c.1504G>A | p.Gly502Arg | missense_variant | Exon 7 of 7 | NP_001158091.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 21
ClinVar
Submissions by phenotype
Simpson-Golabi-Behmel syndrome type 1 Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
The p.G556R variant (also known as c.1666G>A), located in coding exon 8 of the GPC3 gene, results from a G to A substitution at nucleotide position 1666. The glycine at codon 556 is replaced by arginine, an amino acid with dissimilar properties. This alteration was detected in an individual diagnosed with Simpson-Golabi-Behmel syndrome (SGBS) who presented with ischemic stroke due to a dissection of the right internal cartoid artery (Pénisson-Besnier I et al. Am. J. Med. Genet. A, 2008 Feb;146A:464-7). In one functional study, authors showed that this alteration may reduce the ability of GPC3 protein to inhibit Hedgehog signaling during development (Shi W et al. Am. J. Med. Genet. A, 2009 Mar;149A:552-4). In addition, this alteration was detected in two unrelated individuals from a cohort of patients with SGBS phenotypes; however, specific clinical information on these two individuals was not provided (Cottereau E et al. Am J Med Genet C Semin Med Genet, 2013 May;163C:92-105). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
not provided Pathogenic:1
Published functional studies demonstrate that this variant impairs the function of the GPC3 protein (PMID: 19215053); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31826854, 18203194, 29637653, 34547244, 23606591, 19215053) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at